JPH08238300A - Infusion container - Google Patents

Infusion container

Info

Publication number
JPH08238300A
JPH08238300A JP7047472A JP4747295A JPH08238300A JP H08238300 A JPH08238300 A JP H08238300A JP 7047472 A JP7047472 A JP 7047472A JP 4747295 A JP4747295 A JP 4747295A JP H08238300 A JPH08238300 A JP H08238300A
Authority
JP
Japan
Prior art keywords
container
double
ended needle
drug
needle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7047472A
Other languages
Japanese (ja)
Inventor
Tetsushi Miyamoto
哲士 宮本
Mitsuhiro Tadano
光洋 只野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP7047472A priority Critical patent/JPH08238300A/en
Publication of JPH08238300A publication Critical patent/JPH08238300A/en
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3205Separate rigid or semi-rigid containers joined to each other at their external surfaces
    • B65D81/3211Separate rigid or semi-rigid containers joined to each other at their external surfaces coaxially and provided with means facilitating admixture

Abstract

PURPOSE: To aseptically mix a drug and a dissolving soln. by thrusting the lower puncture needle of a double ended needle in the mouth part of a drug container when the cam pressing part of a vial carrier moves downwardly and rotating the double ended needle to release engagement to pierce the hermet ical seal member of the communication port of a dissolving soln. container. CONSTITUTION: When a cap 6 is pressed to move a drug container 1 downwardly, the vial carrier 2 provided to the mouth part of the drug container 1 falls along a guide 31 along with the drug container 1 without being rotated and the upper puncture needle of a double ended needle 4 is thrust in a rubber plug 11. The double ended needle 4 is engaged at the position of the engaging part of a guide capsule 3 before thrusting by an engaging arm but the double ended needle 4 is rotated at a time of thrusting by the cooperation of the cam 42 provided to the upper surface of the hub 41 of the double ended needle 4 and a cam pressing part and the engaging arm is shifted from the position of the engaging part and the engaged state is released and the downward movement of the double ended needle becomes possible and the lower puncture needle of the double ended needle 4 is thrust in the closure film 52 of the communication port 51 of a dissolving soln. container 5.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は輸液用容器に関する。更
に詳しくは、粉末製剤、凍結乾燥製剤等の乾燥薬剤と、
その溶解液を分離した状態で保存しておき、使用直前に
容器内で乾燥薬剤と溶解液を無菌的に混合し、輸液とし
て供給するための輸液用容器に関する。
FIELD OF THE INVENTION The present invention relates to a container for infusion. More specifically, dry drug such as powder formulation and freeze-dried formulation,
The present invention relates to an infusion container for storing the dissolved solution in a separated state, aseptically mixing the dry drug and the dissolved solution in the container immediately before use, and supplying the solution as an infusion solution.

【0002】[0002]

【従来の技術】従来から病院などの医療機関において
は、バイアル等に入った乾燥製剤を蒸留水や生理食塩
水、ブドウ糖液などの溶解液に溶解して点滴注射等に用
いている。この際に、上記薬剤の入った容器とその薬剤
の溶解液の入った容器とを両頭針や連結管等の接続用具
を用いて接続し、溶解液を薬剤の入った容器に移して薬
剤を溶解している。しかしながら、この操作は煩雑で手
間がかかる上、外気中で薬剤の入った容器に接続用の孔
をあける操作を行うので、中の薬剤が汚染される可能性
がある。そこで、上記のような問題点を解消するため、
特表昭61−501129号公報や実開昭63−135
642号公報、特開平2−1277号公報などに示され
るように、薬剤の入った容器をその薬剤の溶解液の入っ
た容器に直列状に連結しておき、使用時にこれら二つの
容器を無菌的に連通するようにした輸液用容器が提案さ
れている。
2. Description of the Related Art Conventionally, in a medical institution such as a hospital, a dried preparation contained in a vial or the like is dissolved in a solution such as distilled water, physiological saline or glucose solution and used for infusion. At this time, the container containing the drug and the container containing the solution of the drug are connected using a connecting tool such as a double-ended needle or a connecting pipe, and the solution is transferred to the container containing the drug to transfer the drug. It is dissolved. However, this operation is complicated and time-consuming, and since the operation of making a connection hole in the container containing the drug in the open air, the drug inside may be contaminated. Therefore, in order to solve the above problems,
Japanese Patent Publication No. Sho 61-501129 and Shokai No. Sho 63-135
As shown in Japanese Patent Laid-Open No. 642 and Japanese Patent Laid-Open No. 2-1277, a container containing a drug is connected in series to a container containing a solution of the drug, and these two containers are sterilized during use. An infusion container adapted to communicate with each other has been proposed.

【0003】特表昭61−501129号公報に示され
るものは、薬剤容器が収容されたカプセルと溶解液が収
容された溶解液容器とがチューブで接続されたものであ
り、チューブ内に設けられた連通手段によって薬剤容器
と溶解液容器とが連通され、薬剤と溶解液とが無菌的に
混合されるようになっている。また、実開昭63−13
5642号公報に示されるものは、溶解液容器の口部の
シール部に筒状の適宜取り外し可能なサポートリングを
設け、このサポートリングに上下スライド自在に両頭針
を取り付けたものであり、両頭針を下方にスライドさせ
たときに、下部針体が溶解液容器の口部のシール部に穿
刺するようにしたものである。また、特開平2−127
7号公報に示されるものは、薬剤容器と溶解液容器との
間に、中間にハブを有し両端に刃先を有する中空の穿刺
針を介在させ、この穿刺針によってまず薬剤容器を刺通
し、次いで溶解液容器を刺通するよう構成し、薬剤容器
と溶解液容器との連通を確実かつ容易にし、連通後の薬
剤と溶解液の混合を短時間で無菌的に行うことができる
ようにした輸液用容器である。
The one disclosed in Japanese Patent Publication No. 61-501129 has a capsule containing a medicine container and a dissolution liquid container containing a dissolution liquid connected by a tube, and is provided in the tube. The drug container and the solution container are communicated by the communicating means, and the drug and the solution are aseptically mixed. Also, the actual development 63-13
Japanese Patent No. 5642 discloses that a cylindrical support ring that is appropriately removable is provided at a seal portion of a mouth of a dissolution liquid container, and a double-ended needle is attached to the support ring so as to be vertically slidable. When the needle is slid downward, the lower needle body pierces the seal portion at the mouth of the solution container. In addition, JP-A-2-127
No. 7 discloses that a hollow puncture needle having a hub in the middle and blade edges at both ends is interposed between a drug container and a solution container, and the drug container is first pierced by the puncture needle, and then An infusion solution configured to pierce the dissolution liquid container to ensure reliable and easy communication between the drug container and the dissolution liquid container, and to allow aseptic mixing of the drug and the dissolution liquid after communication. It is a container for.

【0004】これらの輸液用容器はいずれも乾燥薬剤の
一般的な流通形態であるバイアルをそのまま取り込み、
一体化したものであるので汎用性は高い。しかしなが
ら、例えば、特表昭61−501129号公報の輸液用
容器は、部品点数が多い上、破断部材を手で折って通路
を開通するのに手間を要し、破断部材の折れ方が不完全
な場合には、溶解液がスムースに通りにくく、溶解に時
間を要するという欠点を有している。また、実開昭63
−135642号公報の輸液用容器は、部品点数が少な
く操作は比較的容易であるが、連通に比較的大きな力を
要し、薬剤と溶解液を混合後サポートリング及び両頭針
を取り外して溶解液容器を反転させ、両頭針を抜き取っ
た後の溶解液容器の口部のシール部に輸液セットなどを
接続する必要があるため、操作が煩雑であり、両頭針抜
取時に混合された薬液が漏れるおそれもあるなどの欠点
を有している。また、特開平2−1277号公報の輸液
用容器は、特表昭61−501129号公報と比較して
薬剤容器と溶解液容器の連通は簡素化されているが、全
体に部品点数が多く、連通順序を規制する制動手段等の
部品が複雑であるという欠点を有している。更にその制
動手段となる部品は、外部からの圧力により撓んで変形
することにより作動するので、部品の材質の種類、使用
時の温度変化、使用者が連通操作を行う際の力の入れ具
合等によって部品にクラックが生じ、連通されないとい
う懸念がある。
Each of these infusion containers directly takes in a vial, which is a general distribution form of a dry drug,
Since it is integrated, it is highly versatile. However, for example, the infusion container disclosed in JP-A-61-501129 has a large number of parts, and it takes time to fold the breaking member by hand to open the passage, and the breaking member is incompletely broken. In such a case, the solution is difficult to pass smoothly, and it has a drawback that it takes time to dissolve it. Also, the actual exploitation 63
Although the infusion container of Japanese Patent No. 135642 has a small number of parts and is relatively easy to operate, it requires a relatively large force to communicate with each other, and after mixing the drug and the solution, the support ring and the double-ended needle are removed to dissolve the solution. Since it is necessary to invert the container and connect an infusion set etc. to the seal part at the mouth of the dissolution liquid container after removing the double-ended needle, the operation is complicated, and the mixed chemical solution may leak when the double-ended needle is removed. There are some drawbacks, such as the presence of mist. Further, in the infusion container disclosed in JP-A No. 2-1277, the communication between the drug container and the dissolution container is simplified as compared with JP-A-61-501129, but the number of parts is large as a whole. It has a drawback that parts such as braking means that regulate the communication order are complicated. Furthermore, since the part that serves as the braking means operates by being bent and deformed by pressure from the outside, the type of material of the part, temperature change during use, force input when the user performs communication operation, etc. There is a concern that the parts will crack and will not be communicated.

【0005】[0005]

【発明が解決しようとする課題】本発明は上述の状況に
鑑みてなされたもので、操作が容易で手間がかからず、
混合された薬液が漏れるおそれがなく、部品点数が少な
く、部品形状がシンプルな、無菌的に薬剤と溶解液を混
合することのできる輸液用容器を提供することを目的と
する。本発明のもう一つの目的は確実な連通順序規制手
段を有した輸液用容器を提供することである。
DISCLOSURE OF THE INVENTION The present invention has been made in view of the above situation, and is easy to operate and requires no trouble.
It is an object of the present invention to provide an infusion container capable of aseptically mixing a drug and a solution without the risk of leakage of the mixed drug solution, the number of parts is small, and the shape of parts is simple. Another object of the present invention is to provide an infusion container having a reliable communication sequence regulating means.

【0006】[0006]

【課題を解決するための手段】本発明は上記の課題を解
決するために、口部が穿刺針で刺通可能な栓で密封され
た薬剤容器と、薬液取出口と穿刺針で穿刺可能な密封部
材で密封された薬剤容器との連通口とをその両端に有す
る押圧変形自在な合成樹脂製の溶解液容器と、前記薬剤
容器の口部と前記溶解液容器の連通口の間に介在され
た、上部穿刺針と下部穿刺針及びハブからなる両頭針
と、前記薬剤容器を保持し、該薬剤容器を下方向に移動
させるバイアルキャリアと、開放端と前記溶解液容器の
連通口との結合端及び前記両頭針を係止する係止部とを
有し、前記バイアルキャリアと両頭針を収容して、前記
バイアルキャリアの下方移動を案内するガイドカプセル
と、該ガイドカプセルの解放端を密閉するとともに前記
薬剤容器の一部を収容して保持するキャップとから構成
されており、前記両頭針はそのハブの上面に1対のカム
が軸対称に形成されており、前記バイアルキャリアはそ
の外壁に前記カムと係合して両頭針を回転させる1対の
カム押圧部が形成されており、前記薬剤容器を下方移動
させたとき、両頭針の上部穿刺針によって薬剤容器の口
部が刺通されるとともに、前記両頭針が回転して前記ガ
イドカプセルとの係止状態が解除され、更に薬剤容器と
ともに下方移動し、前記両頭針の下部穿刺針によって溶
解液容器の連通口の密封部材が刺通されることにより、
薬剤容器と溶解液容器とが連通するようにしたことを特
徴とする輸液用容器を採用している。薬剤容器との連通
口は閉鎖膜で閉鎖されたものが好適に採用される。ま
た、両頭針のハブ上面のカムが円弧状の板に形成されて
いてもよい。更にまた、キャップに吊り下げ手段が設け
られていてもよい。
In order to solve the above problems, the present invention is capable of puncturing with a drug container whose mouth is sealed by a stopper that can be pierced by a puncture needle, a drug solution outlet and a puncture needle. A solution container made of a synthetic resin that is press-deformable and has a communication port with a drug container sealed by a sealing member at both ends thereof, and is interposed between the mouth part of the drug container and the communication port of the solution container. Also, a double-ended needle consisting of an upper puncture needle, a lower puncture needle, and a hub, a vial carrier that holds the drug container and moves the drug container downward, and a connection between the open end and the communication port of the dissolution liquid container A guide capsule that has an end and a locking portion that locks the double-ended needle, accommodates the vial carrier and the double-ended needle, and guides the downward movement of the vial carrier, and seals the open end of the guide capsule. Accommodates part of the drug container with A pair of cams is formed on the upper surface of the hub of the double-ended needle in an axially symmetrical manner, and the vial carrier engages with the cam on its outer wall to hold the double-ended needle. A pair of cam pressing portions for rotating is formed, and when the drug container is moved downward, the upper puncture needle of the double-ended needle pierces the mouth of the drug container and the double-ended needle rotates. By releasing the locked state with the guide capsule, further moving downward together with the drug container, by piercing the sealing member of the communication port of the dissolution liquid container by the lower puncture needle of the double-ended needle,
An infusion container characterized in that the drug container and the solution container are communicated with each other is adopted. The communication port with the drug container is preferably closed with a closing film. Further, the cam on the upper surface of the hub of the double-ended needle may be formed in an arc-shaped plate. Furthermore, the cap may be provided with suspending means.

【0007】[0007]

【作用】図1及び図2において、薬剤容器1を保持した
バイアルキャリア2のガイド受け部22がガイドカプセ
ル3の内壁に設けられたガイド31に嵌められている。
そして、両頭針4はガイドカプセル3の内壁に設けられ
た係止部32で予め係止されている。この構成では例え
ばキャップ6を押してバイアルキャリア2と一緒に薬剤
容器1を押し下げた時に、バイアルキャリア2は下方移
動して両頭針4に達し、まず薬剤容器4の口部のゴム栓
11が両頭針4の上部穿刺針43によって刺通される。
両頭針4はそのハブ41上面に設けられたカム42とバ
イアルキャリア2に設けられたカム押圧部21とが係合
しており、バイアルキャリア2はそのガイド受け部22
がガイドカプセル3のガイド31に沿って下方移動する
ので、刺通時に薬剤容器1を保持したバイアルキャリア
2の下方移動にともなって両頭針4は係止部32の位置
で下方移動することなく所定角度、例えば45°回転す
る。すると両頭針4のハブ41は係止部32から脱出し
て下方移動が可能となり、更に薬剤容器1が押し下げら
れ、両頭針4はバイアルキャリア2及び薬剤容器1と一
緒に下方移動し、溶解液容器5の連通口51に設けられ
た密封部材の例えば閉鎖膜52が両頭針4の下部穿刺針
44によって刺通される。このように、薬剤容器を下方
移動させることにより、薬剤容器と溶解液容器との連通
操作は容易に達成され、連通順序の規制は確実に行われ
る。すなわち、薬剤容器1の口部のゴム栓11は先に刺
通され、溶解液容器5の連通口51は後で刺通される。
In FIG. 1 and FIG. 2, the guide receiving portion 22 of the vial carrier 2 holding the drug container 1 is fitted in the guide 31 provided on the inner wall of the guide capsule 3.
The double-ended needle 4 is locked in advance by a locking portion 32 provided on the inner wall of the guide capsule 3. In this configuration, for example, when the cap 6 is pushed and the drug container 1 is pushed down together with the vial carrier 2, the vial carrier 2 moves downward to reach the double-ended needle 4, and first, the rubber stopper 11 at the mouth of the drug container 4 is double-ended. 4 is pierced by the upper puncture needle 43.
The double-ended needle 4 is engaged with a cam 42 provided on the upper surface of the hub 41 thereof and a cam pressing portion 21 provided on the vial carrier 2, and the vial carrier 2 has its guide receiving portion 22.
Moves downward along the guide 31 of the guide capsule 3, so that the double-ended needle 4 does not move downward at the position of the locking portion 32 with the downward movement of the vial carrier 2 that holds the drug container 1 during piercing. Rotate at an angle, for example 45 °. Then, the hub 41 of the double-ended needle 4 comes out of the locking portion 32 and can be moved downward, the drug container 1 is further pushed down, the double-ended needle 4 moves downward together with the vial carrier 2 and the drug container 1, and the solution is dissolved. For example, the closing film 52 of the sealing member provided in the communication port 51 of the container 5 is pierced by the lower puncture needle 44 of the double-ended needle 4. In this way, by moving the drug container downward, the communication operation between the drug container and the dissolution liquid container is easily achieved, and the communication order is reliably regulated. That is, the rubber stopper 11 at the mouth of the drug container 1 is pierced first, and the communication port 51 of the solution container 5 is pierced later.

【0008】なお、この明細書で用いている上下方向な
ど方向を示す用語は、輸液容器を通常の使用状態にした
場合の方向を示し、あくまでも輸液用容器の構成におけ
る理解を容易にするものである。
The terminology used in this specification, such as the vertical direction, indicates the direction when the infusion container is in a normal use state, and is merely to facilitate understanding of the structure of the infusion container. is there.

【0009】[0009]

【実施例】以下本発明の実施例について図面を用いて説
明する。図1は本発明の輸液用容器の一実施例の要部断
面正面図、図2は図1の要部を示す一部断面側面図、図
3は図1のガイドカプセルの平面図、図4は図1のバイ
アルキャリアの一部断面正面図、図5は図4のバイアル
キャリアの平面図、図6はバイアルキャリアの他の実施
例を示す縦断面図、図7は図6のバイアルキャリアの底
面図、図8は図1の両頭針の正面図、図9は図8の両頭
針の平面図、図10及び図11は図1の両頭針とバイア
ルキャリアの作動を説明する説明図である。
Embodiments of the present invention will now be described with reference to the drawings. 1 is a partial sectional front view of an essential part of an infusion container of the present invention, FIG. 2 is a partial sectional side view of the essential part of FIG. 1, FIG. 3 is a plan view of the guide capsule of FIG. 1, and FIG. 1 is a partial sectional front view of the vial carrier of FIG. 1, FIG. 5 is a plan view of the vial carrier of FIG. 4, FIG. 6 is a vertical sectional view of another embodiment of the vial carrier, and FIG. 7 is of the vial carrier of FIG. FIG. 8 is a bottom view, FIG. 8 is a front view of the double-ended needle of FIG. 1, FIG. 9 is a plan view of the double-ended needle of FIG. 8, and FIGS. 10 and 11 are explanatory views for explaining the operation of the double-ended needle of FIG. 1 and the vial carrier. .

【0010】図1及び図2に示すように、本発明の輸液
用容器は薬剤容器1と溶解液容器5、両頭針4、バイア
ルキャリア2、ガイドカプセル3及びキャップ6から構
成されている。ガイドカプセル3はその結合端で溶解液
容器5の首部51に結合され、その開放端はキャップ6
により密閉されている。そして溶解液容器5の首部51
には連通口51が設けられている。バイアルキャリア2
によって口部を下方向にして保持された薬剤容器1はキ
ャップ6及びガイドカプセル3の内部に収容されてい
る。両頭針4はガイドカプセル3に収容され、その内壁
に設けられた係止部32で係止されており、薬剤容器1
の口部のゴム栓11及び溶解液容器5の連通口51の間
に配置されている。従って、キャップ6を押し下げる
と、薬剤容器1がバイアルキャリア2と一緒に下降して
両頭針4の上部穿刺針43によって薬剤容器1の口部の
ゴム栓11が刺通されるとともに、両頭針4が係止位置
で所定角度回転して係止部32から脱出し、更に薬剤容
器1及びバイアルキャリア2と一緒に下降し、その下部
穿刺針44によって溶解液容器5の連通口51の閉鎖膜
52を刺通して両容器を連通し、内部に収容された薬剤
と溶解液の混合を可能にする。
As shown in FIGS. 1 and 2, the infusion container of the present invention comprises a drug container 1, a solution container 5, a double-ended needle 4, a vial carrier 2, a guide capsule 3 and a cap 6. The guide capsule 3 is connected at its connecting end to the neck portion 51 of the dissolution liquid container 5, and its open end is at the cap 6
It is sealed by. And the neck portion 51 of the dissolution liquid container 5
A communication port 51 is provided in the. Vial carrier 2
The drug container 1 held by the mouth portion downward is housed inside the cap 6 and the guide capsule 3. The double-ended needle 4 is housed in the guide capsule 3 and is locked by a locking portion 32 provided on the inner wall of the guide capsule 3.
It is arranged between the rubber stopper 11 at the mouth portion of and the communication port 51 of the solution container 5. Therefore, when the cap 6 is pushed down, the drug container 1 is lowered together with the vial carrier 2, the upper puncture needle 43 of the double-ended needle 4 pierces the rubber stopper 11 at the mouth of the drug container 1, and the double-ended needle 4 Is rotated by a predetermined angle at the locking position to escape from the locking portion 32, and further descends together with the drug container 1 and the vial carrier 2, and the closing membrane 52 of the communication port 51 of the dissolution liquid container 5 by the lower puncture needle 44 thereof. The two containers are pierced with each other to communicate with each other to allow the drug contained in the container and the solution to be mixed.

【0011】薬剤容器1は市販のガラス製やプラスチッ
ク製のものが使用でき、図1に示すように、その口部は
ゴム栓11等の、両頭針4によって刺通可能な自己シー
ル性を有する密封部材で密封されている。口部をより液
密に固定するためにゴム栓11はさらにアルミニウム等
の材質からなるカバー部材で巻締めされることもある。
なお、薬剤容器1内には粉末製剤や凍結乾燥製剤等の乾
燥製剤が収容されているが、図では省略している。
As the drug container 1, a commercially available one made of glass or plastic can be used, and as shown in FIG. 1, its mouth has a self-sealing property such as a rubber stopper 11 which can be pierced by a double-ended needle 4. It is sealed with a sealing member. In order to fix the mouth portion in a more liquid-tight manner, the rubber stopper 11 may be further wound by a cover member made of a material such as aluminum.
It should be noted that although a dry preparation such as a powder preparation or a freeze-dried preparation is contained in the drug container 1, it is omitted in the figure.

【0012】薬剤容器1を図1に示すように保持すると
ともに、薬剤容器1を下方移動させるための補助具とし
て機能するバイアルキャリア2は、通常ポリエチレンや
ポリプロピレン、ポリエステル、ポリ塩化ビニル、ポリ
カーボネート、ABS樹脂などの合成樹脂で形成されて
おり、図4〜5に示すように、後述の薬剤容器1の口部
に装着される短筒状の部材で、その外壁にはカム押圧部
21とガイド受け部22が形成されている。そしてその
底部には後述の両頭針4の上部穿刺針43を穿刺する位
置に透孔25が形成されている。
The vial carrier 2 that holds the drug container 1 as shown in FIG. 1 and functions as an auxiliary tool for moving the drug container 1 downward is usually polyethylene, polypropylene, polyester, polyvinyl chloride, polycarbonate, ABS. As shown in FIGS. 4 to 5, it is a short tubular member that is formed of a synthetic resin such as resin and is attached to the mouth of the drug container 1 described later, and has a cam pressing portion 21 and a guide receiving portion on its outer wall. The part 22 is formed. A through hole 25 is formed in the bottom of the double-ended needle 4 at a position where the upper puncture needle 43 is punctured.

【0013】カム押圧部21は、両頭針4のハブ41の
上面に形成されたカム42と係合してこれを押圧し、係
止位置で両頭針4を回転させる機能を有している。図で
はこのカム押圧部21はバイアルキャリア2の外壁に中
心軸に対し対称に1対のリブとして形成されている。カ
ム押圧部21より90°ずれた位置に軸対称に1対のリ
ブの形状をしたガイド受け部22が形成されている。ガ
イド受け部22は後述のガイドカプセル3の内壁に形成
されたガイド31に嵌め込まれており、バイアルキャリ
ア2を回転不能に拘束し、ガイド31に沿っての下方移
動のみを可能としている。
The cam pressing portion 21 has a function of engaging a cam 42 formed on the upper surface of the hub 41 of the double-ended needle 4 to press it, and rotate the double-ended needle 4 at the locking position. In the figure, the cam pressing portion 21 is formed on the outer wall of the vial carrier 2 as a pair of ribs symmetrical with respect to the central axis. A pair of guide receiving portions 22 each having an axially symmetrical shape are formed at a position deviated from the cam pressing portion 21 by 90 °. The guide receiving portion 22 is fitted in a guide 31 formed on the inner wall of a guide capsule 3 described later, restrains the vial carrier 2 so that it cannot rotate, and only allows downward movement along the guide 31.

【0014】バイアルキャリア2には薬剤容器1を脱落
しないよう装着するために、その上部側壁に複数のスリ
ット23を設けたり、上部内壁に環状のアンダーカット
を設けたりしてもよい。図5ではスリット23は3箇所
設けられている。これらを設けることにより、薬剤容器
1の口部の口径が多少異なるものでも使用できる。バイ
アルキャリア2はカム押圧部21とガイド受け部22を
有し、薬剤容器1を保持するような構成であれば形状は
これに限定されず、例えば図6〜7に示すように、薬剤
容器1の口部に装着される短筒状の部材に1対のアーム
26が軸対称に形成されており、短筒状の部材の外壁に
カム押圧部21が設けられ、アーム26の下端にガイド
受け部22が、アーム26の上端に薬剤容器1の底部を
保持するツメ27が設けられた構成のものも好適に採用
される。
In order to mount the drug container 1 on the vial carrier 2 so as not to fall off, a plurality of slits 23 may be provided on the upper side wall thereof, or an annular undercut may be provided on the upper inner wall thereof. In FIG. 5, three slits 23 are provided. By providing these, it is possible to use the medicine container 1 having a slightly different opening diameter. The vial carrier 2 has a cam pressing portion 21 and a guide receiving portion 22, and the shape is not limited to this as long as it holds the drug container 1. For example, as shown in FIGS. A pair of arms 26 are axially symmetrically formed on a short tubular member attached to the mouth of the arm, a cam pressing portion 21 is provided on the outer wall of the short tubular member, and a guide receiving member is provided at the lower end of the arm 26. A configuration in which the portion 22 is provided with a claw 27 for holding the bottom portion of the medicine container 1 on the upper end of the arm 26 is also suitably adopted.

【0015】薬剤容器1を保持したバイアルキャリア2
はその一部が両頭針4とともにガイドカプセル3に収容
される。ガイドカプセル3は通常、バイアルキャリア2
と同様の合成樹脂で形成された略筒状の部材で、図1〜
2に示すように両端に解放端と結合端を有している。解
放端側にはその外壁に環状突起33が形成されており、
キャップ6が気密かつ摺動可能に結合されている。一
方、結合端側には後述の溶解液容器5の首部54と結合
するための結合部34が環状に設けられており、ガイド
カプセル3の内壁には結合端から解放端に向かって縦走
する1対のガイド31が軸対称に形成されている。
A vial carrier 2 holding a drug container 1
Part of it is housed in the guide capsule 3 together with the double-ended needle 4. The guide capsule 3 is usually a vial carrier 2
1 is a substantially cylindrical member made of a synthetic resin similar to
As shown in 2, it has a release end and a coupling end at both ends. An annular projection 33 is formed on the outer wall of the open end side,
A cap 6 is airtightly and slidably connected. On the other hand, a coupling portion 34 for coupling with a neck portion 54 of the dissolution liquid container 5 described later is provided on the coupling end side in an annular shape, and the inner wall of the guide capsule 3 runs longitudinally from the coupling end to the release end. The pair of guides 31 are formed in axial symmetry.

【0016】このガイド31はバイアルキャリア2の1
対のガイド受け部22と嵌合してバイアルキャリア2を
回転させずに下方移動させるためのもので、図3に示す
ように、2本の縦リブ311、312によって摺動溝3
13を形成したもので、軸対称に1対形成されている。
なお、図ではガイド31とガイド受け部22は相互の嵌
合の関係から1対に形成されているが、それぞれ複数形
成されていてもよい。更にまた、ガイド31にリブを構
成し、ガイド受け部22にガイド31と嵌合するような
溝を構成してもよい。要するに、バイアルキャリア2が
回転しないでガイドに沿って下方移動するように嵌合し
ていれば相互の嵌合形状等はこれに限定されない。
This guide 31 is a part of the vial carrier 2
It is for fitting the pair of guide receiving portions 22 and moving the vial carrier 2 downward without rotating it. As shown in FIG. 3, the sliding groove 3 is formed by two vertical ribs 311 and 312.
13 are formed, and one pair is formed axially symmetrically.
In the figure, the guide 31 and the guide receiving portion 22 are formed as a pair due to the mutual fitting relationship, but a plurality of each may be formed. Furthermore, the guide 31 may be formed with a rib, and the guide receiving portion 22 may be formed with a groove that fits with the guide 31. In short, mutual fitting shapes and the like are not limited to this as long as the vial carrier 2 is fitted so as to move downward along the guide without rotating.

【0017】ガイドカプセル3の結合端側内壁には後述
の両頭針4が係止される係止部32が設けられている。
この係止部32は両頭針4が所定角度回転することによ
りこれから脱出して、両頭針4の下方移動が可能となる
ように構成されている。すなわち、図3に示すように、
同心円上に軸対称に形成された1対の段部として形成さ
れている。更に好ましくは結合端側内壁の形状は結合端
から開放端へ向かって、拡径するテーパ形状に構成され
ている。結合端側内壁の形状は必ずしもテーパ形状に構
成しなくてもよいが、このように構成することにより、
両頭針4が掛止部32から脱出して下方移動する際、内
壁に相当の圧力で押さえつけられながら徐々に下降して
いくので都合がよい。
A locking portion 32 for locking a double-ended needle 4 described later is provided on the inner wall of the guide capsule 3 on the coupling end side.
The locking portion 32 is configured so that the double-ended needle 4 can be moved out of the double-ended needle 4 by rotating the double-ended needle 4 by a predetermined angle, and the double-ended needle 4 can be moved downward. That is, as shown in FIG.
It is formed as a pair of axially symmetric stepped portions on a concentric circle. More preferably, the shape of the inner wall of the joint end side is formed in a taper shape in which the diameter increases from the joint end toward the open end. The shape of the inner wall on the coupling end side does not necessarily have to be a tapered shape, but with such a configuration,
When the double-ended needle 4 escapes from the hook portion 32 and moves downward, it is convenient because it is gradually lowered while being pressed against the inner wall with a considerable pressure.

【0018】結合部34は後述の溶解液容器5の首部5
4と液密に結合する部分であり、図では溶着により結合
されている。この結合は溶着のみに限定されず、例えば
螺合や嵌合により結合されていてもよく、更にガイドカ
プセルと溶解液容器は一体に成形されていてもよい。
The connecting portion 34 is a neck portion 5 of the dissolution liquid container 5 described later.
4 is a portion that is liquid-tightly coupled to the nozzle 4 and is welded in the figure. This connection is not limited to welding, but may be, for example, screwing or fitting, and the guide capsule and the solution container may be integrally formed.

【0019】連通手段として採用される両頭針4は図1
に示すように薬剤容器1と溶解液容器5の間に配置され
ており、通常ステンレス鋼(SUS304が好ましい)
または合成樹脂製のカヌラと合成樹脂製のハブが好まし
い。しかしながら廃棄の問題及び一体成形できるという
点から、合成樹脂製のもの、例えば高密度ポリエチレン
やABS樹脂、ポリカーボネート製のもの等が好適に採
用される。両頭針4は図8〜9に示すように、バイアル
キャリア2に保持されてこれと一緒に下降してきた薬剤
容器1の口部のゴム栓11を刺通する上部穿刺針43
と、溶解液容器5の連通口51の閉鎖膜52を刺通する
下部穿刺針44、及び上部穿刺針43と下部穿刺針44
の間に連通順序を規制する制動手段としてのハブ41と
から構成されている。
The double-ended needle 4 used as the communication means is shown in FIG.
It is placed between the drug container 1 and the solution container 5 as shown in FIG. 1, and is usually made of stainless steel (SUS304 is preferable).
Alternatively, a synthetic resin canula and a synthetic resin hub are preferable. However, from the viewpoint of disposal and integral molding, those made of synthetic resin, for example, those made of high-density polyethylene, ABS resin, polycarbonate, etc. are preferably adopted. As shown in FIGS. 8 to 9, the double-ended needle 4 is an upper puncture needle 43 that pierces the rubber stopper 11 of the mouth of the drug container 1 held by the vial carrier 2 and descended together with the vial carrier 2.
And a lower puncture needle 44 that pierces the closing membrane 52 of the communication port 51 of the dissolution liquid container 5, and an upper puncture needle 43 and a lower puncture needle 44.
And a hub 41 as a braking unit that regulates the communication order.

【0020】ハブ41の上面の外周には同心円上にカム
42が軸対称に1対構成されており、バイアルキャリア
2のカム押圧部21と係合するようになっている。従っ
て、バイアルキャリア2が下降すると、バイアルキャリ
ア2が回転不能になっている関係で、カム42はカム押
圧部21と当接し押圧されて両頭針4に回転運動を与え
る。図ではこのカム42はハブ41の上面外周に円弧状
の板として構成されているが、カムの形状はこれに限定
されず、例えばハブ41の外周側壁にカムが螺旋状の段
部として構成されていてもよい。更にハブ41の外周に
はガイドカプセル3の係止部32で係止されるよう突起
状の係止腕45が同心円上に軸対称に1対形成されてい
る。この係止腕45は係止部32との関係から1対に形
成されている。46は両頭針4の中心部を貫通している
薬液通路であり、図では2つ形成されているが、薬液通
路の数は1つであってもよい。
A pair of cams 42 are concentrically arranged on the outer periphery of the upper surface of the hub 41 so as to be axially symmetric, and engage with the cam pressing portion 21 of the vial carrier 2. Therefore, when the vial carrier 2 descends, the cam 42 comes into contact with the cam pressing portion 21 and is pressed by the relationship that the vial carrier 2 cannot rotate, thereby giving the double-ended needle 4 a rotational movement. In the figure, the cam 42 is formed as an arcuate plate on the outer periphery of the upper surface of the hub 41, but the shape of the cam is not limited to this. For example, the cam is formed as a spiral step on the outer peripheral side wall of the hub 41. May be. Further, on the outer periphery of the hub 41, a pair of projecting locking arms 45 are formed concentrically and axially symmetrically so as to be locked by the locking portion 32 of the guide capsule 3. The locking arms 45 are formed in a pair due to the relationship with the locking portion 32. Reference numeral 46 denotes a chemical liquid passage that penetrates the central portion of the double-ended needle 4, and two chemical liquid passages are formed in the figure, but the number of chemical liquid passages may be one.

【0021】溶解液容器5は比較的柔らかい合成樹脂で
形成された押圧変形自在なもので、一般にポリエチレン
やポリプロピレン、エチレン酢酸ビニル共重合体、ポリ
塩化ビニル、ポリエステル等の合成樹脂で形成されてい
る。図1に示すように溶解液容器5の上端に連通口51
の設けられた首部54が形成されており、下端に薬液取
出口53が形成されている。連通口51は穿刺針で刺通
可能な密封部材で密封されており、例えば図では閉鎖膜
52で密封されている。この閉鎖膜52は溶解液容器5
と同様の合成樹脂の、厚み0.1〜0.8mmの薄膜と
して形成されているが、密封部材はこれに限定されず、
例えばゴム栓等のゴム弾性体を用いても好適に採用され
る。薬液取出口は輸液セット等と連結可能に、ゴム栓等
のゴム弾性体で形成された密封部材が装着されているも
のが好ましい。なお、溶解液容器5内には蒸留水や生理
食塩水、ブドウ糖液等の溶解液が収容されているが図で
は省略している。
The solution container 5 is made of a relatively soft synthetic resin and is deformable by pressing, and is generally made of a synthetic resin such as polyethylene, polypropylene, ethylene vinyl acetate copolymer, polyvinyl chloride or polyester. . As shown in FIG. 1, a communication port 51 is provided at the upper end of the solution container 5.
Is formed, and the chemical solution outlet 53 is formed at the lower end. The communication port 51 is sealed with a sealing member that can be pierced by a puncture needle, and is sealed with, for example, a closing film 52 in the figure. This closing film 52 is used for the solution container 5
It is formed as a thin film of a synthetic resin similar to the above with a thickness of 0.1 to 0.8 mm, but the sealing member is not limited to this.
For example, a rubber elastic body such as a rubber plug is also preferably used. It is preferable that the drug solution outlet is equipped with a sealing member formed of a rubber elastic body such as a rubber plug so that it can be connected to an infusion set or the like. Note that a solution such as distilled water, physiological saline, or glucose solution is contained in the solution container 5, but it is omitted in the figure.

【0022】キャップ6は図1に示すように、ガイドカ
プセル3の解放端を密閉するとともに、薬剤容器1の一
部を収容して保持しており、通常ガイドカプセル3と同
様の合成樹脂で筒状に形成される。キャップ6の下端部
内壁にはガイドカプセル3と気密に結合して摺動可能な
ように、ゴム弾性体で形成されたOリング61が装着さ
れており、ガイドカプセル3の開放端側外壁に設けられ
た環状突起33と係合している。キャップ6の上面内壁
は薬剤容器1の底部と当接しており、キャップ6を押し
下げることにより、薬剤容器1が下方移動するようにな
っている。図ではキャップ6とガイドカプセル3は間に
Oリング61を介在させて結合されているが、気密にか
つ摺動可能な結合であればこれに限定されず、例えば螺
合により結合されていてもよい。螺合の場合、薬剤容器
1はキャップ6を回転させることにより下方へ移動す
る。
As shown in FIG. 1, the cap 6 hermetically seals the open end of the guide capsule 3 and holds and holds a part of the medicine container 1. The cap 6 is usually made of the same synthetic resin as the guide capsule 3 and is a cylinder. Formed into a shape. An O-ring 61 formed of a rubber elastic body is attached to the inner wall of the lower end of the cap 6 so as to be airtightly coupled to the guide capsule 3 and slidable, and provided on the outer wall of the open end side of the guide capsule 3. Is engaged with the annular projection 33. The inner wall of the upper surface of the cap 6 is in contact with the bottom of the drug container 1, and the drug container 1 is moved downward by pushing down the cap 6. In the figure, the cap 6 and the guide capsule 3 are connected with an O-ring 61 interposed therebetween, but the connection is not limited to this as long as it is an airtight and slidable connection, and for example, it may be connected by screwing. Good. In the case of screwing, the medicine container 1 moves downward by rotating the cap 6.

【0023】なお、両頭針4が薬剤容器1の口部に刺通
されることによって薬剤容器1のゴム栓11が切断さ
れ、その切断片が薬剤容器1内に混じり込むといった、
いわゆるコアリングによる異物の発生を回避するため
に、例えばキャップ6の上面内壁の中心部に小さな突起
を設け、薬剤容器1が刺通時に両頭針と一緒に回転する
ような構成にするとより好ましい。更にまた、キャップ
6の上面外壁には図1に示すように吊り下げ手段62を
設けると、混合された薬液を薬液取出口から輸液セット
等を用いて取り出す際、ハンガーに吊り下げられるので
好都合である。
The double-ended needle 4 is pierced through the mouth of the medicine container 1 to cut the rubber stopper 11 of the medicine container 1, and the cut pieces are mixed into the medicine container 1.
In order to avoid the generation of foreign matter due to so-called coring, it is more preferable to provide a small protrusion, for example, at the center of the inner wall of the upper surface of the cap 6 so that the medicine container 1 rotates together with the double-ended needle during piercing. Furthermore, if a suspending means 62 is provided on the outer wall of the upper surface of the cap 6 as shown in FIG. 1, it is convenient because it can be suspended on a hanger when the mixed drug solution is taken out from the drug solution outlet using an infusion set or the like. is there.

【0024】次に本発明の輸液用容器の両頭針により連
通される状態を図1、図10、図11を用いて詳しく説
明する。キャップ6を押して薬剤容器1を下方移動させ
ると、薬剤容器1の口部に装着されたバイアルキャリア
2は、これのガイド受け部22とガイドカプセル3のガ
イド31とが嵌合しているので、回転することなく薬剤
容器1とともにガイド31に沿って下降する(図1)。
そして、薬剤容器1の口部のゴム栓11が、両頭針4の
上部穿刺針43によって刺通される。両頭針4は刺通前
はガイドカプセル3の係止部32の位置で係止腕45に
より掛止されているが、刺通時に両頭針4のハブ41上
面に設けられたカム42と、バイアルキャリア2に設け
られたカム押圧部21との協働により両頭針4が回転
し、係止腕45が係止部32の位置からはずれて係止状
態が解除され、両頭針4の下方移動が可能となる(図1
0)。刺通後更にキャップ6を押して薬剤容器1を下方
移動させると、両頭針4はバイアルキャリア2及び薬剤
容器1とともに下方移動し、下部穿刺針44によって溶
解液容器5の連通口51の閉鎖膜52が刺通される(図
11)。
Next, the state in which the infusion container of the present invention is communicated with the double-ended needle will be described in detail with reference to FIGS. 1, 10, and 11. When the cap 6 is pushed to move the drug container 1 downward, the vial carrier 2 attached to the mouth of the drug container 1 has the guide receiving portion 22 of the vial carrier 2 and the guide 31 of the guide capsule 3 fitted together. It descends along the guide 31 together with the medicine container 1 without rotating (FIG. 1).
Then, the rubber stopper 11 at the mouth of the drug container 1 is pierced by the upper puncture needle 43 of the double-ended needle 4. The double-ended needle 4 is hooked by the locking arm 45 at the position of the locking portion 32 of the guide capsule 3 before the piercing, but at the time of piercing, the cam 42 provided on the upper surface of the hub 41 of the double-ended needle 4 and the vial. The double-ended needle 4 rotates in cooperation with the cam pressing portion 21 provided on the carrier 2, the locking arm 45 is disengaged from the position of the locking portion 32 and the locked state is released, and the downward movement of the double-ended needle 4 is prevented. It becomes possible (Fig. 1
0). When the drug container 1 is further moved by pushing the cap 6 after the piercing, the double-ended needle 4 moves downward together with the vial carrier 2 and the drug container 1, and the lower puncture needle 44 closes the closing membrane 52 of the communication port 51 of the dissolution liquid container 5. Is pierced (Fig. 11).

【0025】こうして、薬剤容器1と溶解液容器5とが
両頭針4を介して連通されると、次に溶解液容器5を上
にして押圧すれば、溶解液を薬剤容器1内へ流入させて
粉末製剤等の薬剤を溶解し薬液とすることができる。次
にキャップ6に設けられた吊り下げ手段62を用いてハ
ンガー等に架け、溶解液容器5をポンピングして薬剤容
器1内の薬液を溶解液容器5内へ戻し、薬液取出口53
に輸液セット等を結合させれば輸液治療に用いることが
できる。
In this way, when the drug container 1 and the solution container 5 are communicated with each other via the double-ended needle 4, the solution container 5 is then pushed upward to allow the solution to flow into the drug container 1. Thus, a drug such as a powder formulation can be dissolved into a drug solution. Next, the hanging means 62 provided on the cap 6 is used to hang it on a hanger or the like, and the solution container 5 is pumped to return the drug solution in the drug container 1 back into the solution container 5 to remove the drug solution outlet 53.
When combined with an infusion set or the like, it can be used for infusion therapy.

【0026】なお、本発明の輸液用容器の形状につい
て、例えば上記実施例では両頭針4にカム42が、バイ
アルキャリア2にカム押圧部21が設けられた構成であ
るが、バイアルキャリア2にカムが、両頭針4にカム押
圧部が設けられた構成であってもよい等、上記記載の実
施例には限定されず、種々の変更及び変形が可能であ
る。
Regarding the shape of the infusion container of the present invention, for example, in the above-mentioned embodiment, the double-ended needle 4 is provided with the cam 42 and the vial carrier 2 is provided with the cam pressing portion 21, but the vial carrier 2 is provided with the cam. However, the present invention is not limited to the embodiment described above, such as the structure in which the double-ended needle 4 is provided with the cam pressing portion, and various changes and modifications are possible.

【0027】[0027]

【発明の効果】以上のように本発明の輸液用容器を採用
することにより、混合操作が簡単で手間がかからず、部
品点数が少なく、部品形状がシンプルな、無菌的に薬剤
と溶解液を混合することのできる輸液用容器を提供する
ことができる。更に、両頭針は溶解液容器内への刺通に
先立って、確実に薬剤容器内へ刺通されるので、薬液が
ガイドカプセル内に漏れることはない。更にまた、両頭
針が薬剤容器の口部密封部材へ刺通される際、制動手段
であるハブが撓んで変形することがないので、部品にク
ラックが生じにくく、使用者が異なっても確実に連通操
作が行える。
As described above, by adopting the infusion container of the present invention, the mixing operation is simple and labor-free, the number of parts is small, the shape of parts is simple, and the drug and solution are aseptically It is possible to provide an infusion container in which the above can be mixed. Furthermore, since the double-ended needle is reliably pierced into the drug container prior to piercing into the solution container, the drug solution does not leak into the guide capsule. Furthermore, when the double-ended needle is pierced into the mouth-sealing member of the drug container, the hub that is the braking means does not bend and deform, so that cracks are less likely to occur in the parts and even if the user is different Communication operation can be performed.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の輸液用容器の一実施例を示す要部断面
正面図である。
FIG. 1 is a sectional front view of a main part showing an embodiment of an infusion container of the present invention.

【図2】図1の要部を示す一部断面側面図である。FIG. 2 is a partial cross-sectional side view showing a main part of FIG.

【図3】図1のガイドカプセルの平面図である。FIG. 3 is a plan view of the guide capsule of FIG.

【図4】図1のバイアルキャリアの一部断面正面図であ
る。
4 is a partial cross-sectional front view of the vial carrier of FIG.

【図5】図4のバイアルキャリアの平面図である。5 is a plan view of the vial carrier of FIG. 4. FIG.

【図6】バイアルキャリアの他の実施例を示す縦断面図
である。
FIG. 6 is a vertical sectional view showing another embodiment of the vial carrier.

【図7】図6のバイアルキャリアの底面図である。FIG. 7 is a bottom view of the vial carrier of FIG.

【図8】図1の両頭針の正面図である。8 is a front view of the double-ended needle of FIG. 1. FIG.

【図9】図8の両頭針の平面図である。9 is a plan view of the double-ended needle of FIG. 8. FIG.

【図10】図1の両頭針とバイアルキャリアの作動を説
明する説明図である。
FIG. 10 is an explanatory diagram for explaining the operation of the double-ended needle and the vial carrier of FIG. 1.

【図11】図1の両頭針とバイアルキャリアの作動を説
明する説明図である。
FIG. 11 is an explanatory diagram for explaining the operation of the double-ended needle and the vial carrier of FIG. 1.

【符号の説明】[Explanation of symbols]

1.薬剤容器 2.バイアルキャリア 3.ガイドカプセル 4.両頭針 5.溶解液容器 6.キャップ 11.ゴム栓 21.カム押圧部 22.ガイド受け部 31.ガイド 32.係止部 33.環状突起 34.結合部 41.ハブ 42.カム 43.上部穿刺針 44.下部穿刺針 45.係止腕 51.連通口 52.閉鎖膜 53.薬液取出口 54.首部 1. Drug container 2. Vial carrier 3. Guide capsule 4. Double-ended needle 5. Dissolution container 6. Cap 11. Rubber stopper 21. Cam pressing part 22. Guide receiving part 31. Guide 32. Locking part 33. Annular protrusion 34. Coupling part 41. Hub 42. Cam 43. Upper puncture needle 44. Lower puncture needle 45. Locking arm 51. Communication port 52. Closure membrane 53. Chemical solution outlet 54. Neck

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 口部が穿刺針で刺通可能な栓で密封され
た薬剤容器と、薬液取出口と穿刺針で穿刺可能な密封部
材で密封された薬剤容器との連通口とをその両端に有す
る押圧変形自在な合成樹脂製の溶解液容器と、前記薬剤
容器の口部と前記溶解液容器の連通口の間に介在され
た、上部穿刺針と下部穿刺針及びハブからなる両頭針
と、前記薬剤容器を保持し、該薬剤容器を下方向に移動
させるバイアルキャリアと、開放端と前記溶解液容器の
連通口との結合端及び前記両頭針を係止する係止部とを
有し、前記バイアルキャリアと両頭針を収容して、前記
バイアルキャリアの下方移動を案内するガイドカプセル
と、該ガイドカプセルの解放端を密閉するとともに前記
薬剤容器の一部を収容して保持するキャップとから構成
されており、前記両頭針はそのハブの上面に1対のカム
が軸対称に形成されており、前記バイアルキャリアはそ
の外壁に前記カムと係合して両頭針を回転させる1対の
カム押圧部が形成されており、前記薬剤容器を下方移動
させたとき、両頭針の上部穿刺針によって薬剤容器の口
部が刺通されるとともに、前記両頭針が回転して前記ガ
イドカプセルとの係止状態が解除され、更に薬剤容器と
ともに下方移動し、前記両頭針の下部穿刺針によって溶
解液容器の連通口の密封部材が刺通されることにより、
薬剤容器と溶解液容器とが連通するようにしたことを特
徴とする輸液用容器。
1. A drug container whose mouth is sealed by a stopper that can be pierced by a puncture needle, and a communication port between a drug solution outlet and a drug container which is sealed by a sealing member that can be punctured by a puncture needle. And a solution container made of a synthetic resin that can be deformed by pressure, and a double-ended needle consisting of an upper puncture needle, a lower puncture needle, and a hub, which is interposed between the mouth of the drug container and the communication port of the solution container. A vial carrier for holding the drug container and moving the drug container downward, a connecting end between an open end and a communication port of the dissolution liquid container, and a locking portion for locking the double-ended needle. A guide capsule for accommodating the vial carrier and the double-ended needle to guide downward movement of the vial carrier; and a cap for sealing the open end of the guide capsule and accommodating and holding a part of the drug container. Is composed of the double-ended needle Has a pair of cams formed axially symmetrically on the upper surface of its hub, and the vial carrier has a pair of cam pressing portions formed on its outer wall for engaging the cams and rotating the double-ended needle. When the drug container is moved downward, the mouth part of the drug container is pierced by the upper puncture needle of the double-ended needle, and the double-ended needle rotates to release the locked state with the guide capsule, By moving downward with the container, and by piercing the sealing member of the communication port of the dissolution liquid container with the lower puncture needle of the double-ended needle,
An infusion container characterized in that a drug container and a solution container are communicated with each other.
【請求項2】 薬剤容器との連通口が、閉鎖膜で閉鎖さ
れた溶解液容器である請求項1記載の輸液用容器。
2. The infusion container according to claim 1, wherein the communication port with the drug container is a dissolution liquid container closed with a closing membrane.
【請求項3】 両頭針のハブ上面のカムが円弧状の板に
形成されてなる請求項1〜2記載の輸液用容器。
3. The infusion container according to claim 1, wherein the cam on the upper surface of the hub of the double-ended needle is formed into an arc-shaped plate.
【請求項4】 キャップに吊り下げ手段を設けてなる請
求項1〜3記載の輸液用容器。
4. The infusion container according to claim 1, wherein the cap is provided with suspending means.
JP7047472A 1995-03-07 1995-03-07 Infusion container Pending JPH08238300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7047472A JPH08238300A (en) 1995-03-07 1995-03-07 Infusion container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7047472A JPH08238300A (en) 1995-03-07 1995-03-07 Infusion container

Publications (1)

Publication Number Publication Date
JPH08238300A true JPH08238300A (en) 1996-09-17

Family

ID=12776094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7047472A Pending JPH08238300A (en) 1995-03-07 1995-03-07 Infusion container

Country Status (1)

Country Link
JP (1) JPH08238300A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003102807A (en) * 2001-09-28 2003-04-08 Showa Denko Plastic Products Co Ltd Vial guide, needle case, and infusion container
JP2007313359A (en) * 1998-09-15 2007-12-06 Baxter Internatl Inc Sliding reconstitution device for diluent container
CN102716035A (en) * 2012-07-02 2012-10-10 重庆莱美药业股份有限公司 Short-course preassembling type dosing instrument
JP2014505505A (en) * 2010-12-10 2014-03-06 フレゼニウス メディカル ケアー ドイチュラント ゲゼルシャフト ミット ベシュレンクテル ハフツング Inserts and vials for injecting liquids
US9839581B2 (en) 2012-04-06 2017-12-12 Chongqing Lummy Pharmaceutical Co., Ltd. Preassembled medicine mixer
CN107951711A (en) * 2016-10-17 2018-04-24 江苏金扬子包装科技有限公司 The mixed medicine formula polypropylene connector of infusion
CN111787899A (en) * 2018-02-27 2020-10-16 赤盾医疗有限公司 Device for securing connection of components
CN112278606A (en) * 2020-10-16 2021-01-29 彭程 Pop can with automatic heating function

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007313359A (en) * 1998-09-15 2007-12-06 Baxter Internatl Inc Sliding reconstitution device for diluent container
JP2003102807A (en) * 2001-09-28 2003-04-08 Showa Denko Plastic Products Co Ltd Vial guide, needle case, and infusion container
JP2014505505A (en) * 2010-12-10 2014-03-06 フレゼニウス メディカル ケアー ドイチュラント ゲゼルシャフト ミット ベシュレンクテル ハフツング Inserts and vials for injecting liquids
US9539387B2 (en) 2010-12-10 2017-01-10 Fresenius Medical Care Deutschalnd Gmbh Insert and vial for the infusion of liquids
TWI586349B (en) * 2010-12-10 2017-06-11 費森尤斯德國醫藥護理股份有限公司 Insert and vial for the infusion of liquids, vial-insert assembly for the infusion of liquids and method for transferring a liquid from a vial to another receptacle
US9839581B2 (en) 2012-04-06 2017-12-12 Chongqing Lummy Pharmaceutical Co., Ltd. Preassembled medicine mixer
CN102716035A (en) * 2012-07-02 2012-10-10 重庆莱美药业股份有限公司 Short-course preassembling type dosing instrument
CN107951711A (en) * 2016-10-17 2018-04-24 江苏金扬子包装科技有限公司 The mixed medicine formula polypropylene connector of infusion
CN111787899A (en) * 2018-02-27 2020-10-16 赤盾医疗有限公司 Device for securing connection of components
CN111787899B (en) * 2018-02-27 2023-07-07 赤盾医疗有限公司 Device for guaranteeing connection safety of devices
CN112278606A (en) * 2020-10-16 2021-01-29 彭程 Pop can with automatic heating function

Similar Documents

Publication Publication Date Title
JPH08126683A (en) Container for transfusion
US5342346A (en) Fluid container
US5902298A (en) Medicament container stopper with integral spike access means
US5533994A (en) Storage and transfer bottle designed for storing two components of a medicamental substance
US5921419A (en) Universal stopper
JPH06239352A (en) Solution injection set
JPH05317383A (en) Solution container equipped with means for communicating with chemical container
JPH0572830B2 (en)
JP2000185085A (en) Lid of medical container with integral spike insertion means provided with recess
US5257986A (en) Container for the separate sterile storage of at least two substances and for mixing said substances
JPH0686738U (en) Medical container
JPH08238300A (en) Infusion container
US7115117B2 (en) Infusion vessel
JP3514505B2 (en) Manufacturing method of solution container
JP2551318B2 (en) Infusion container
JPH08257101A (en) Dissolution liquid injection set
WO1995000101A1 (en) Medical container
JP3345860B2 (en) Infusion container
JP3070044B2 (en) Infusion container with communication means
JP3577105B2 (en) Infusion container
US6019752A (en) Fluid vessel
JP2550858B2 (en) Infusion container
JPH04253863A (en) Transfusion container
JPH05317384A (en) Container of liquid for transfusion
JP2555163Y2 (en) Infusion container